Name: Latest research reports of Aarti Drugs Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: Aarti Drugs Ltd.
Rating: 5
Author: Axis Direct

Aarti Drugs Ltd.

NSE: AARTIDRUGS | BSE: 524348 | ISIN: INE767A01016 | Industry: Pharmaceuticals
| Mid-range Performer

422.7500 9.95 (2.41%)

NSE Jul 31, 2026 15:31 PM

32.54% Gain from 52W Low

Volume: 187.4K

Aarti Drugs Ltd.

30 Oct 2022

422.75

2.41%

Result Update:Aarti Drugs

Buy: Aarti Drugs Ltd.

Recommendation Target

Axis Direct

Aarti Drugs could be benefitted in upcoming quarters, we upgrade to BUY on Aarti Drugs with Target Price of Rs 545

Aarti Drugs Ltd. is trading above all available SMAs